Patients who experienced new-onset DR at follow-up tended to be female, younger, with a longer duration of diabetes, on insulin, and had higher HbA1c and greater visceral obesity at baseline than their counterparts (Table 1). The gene discussed is INS; the disease is diabetes mellitus.